Ensure your Life Science Company Survives Investor Due Diligence
By Robert Thomas, Audit Senior Manager, WithumSmith+Brown, PC and Christian Kelly, IT Auditor, Xantrion Inc. Congratulations! Your pharmaceutical, biologic, or medical device startup has developed a promising product, and you’re ready to raise a Series B round of funding. Read on to learn what experts Rob Thomas and Christian Kelly recommend to make it easier to pursue and obtain that…